Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

260 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reply to Finsterer.
Kanberg N, Schöll M, Edén A, Gisslén M. Kanberg N, et al. Among authors: scholl m. J Infect Dis. 2024 Mar 14;229(3):920-921. doi: 10.1093/infdis/jiad549. J Infect Dis. 2024. PMID: 38036488 No abstract available.
Viral Antigen and Inflammatory Biomarkers in Cerebrospinal Fluid in Patients With COVID-19 Infection and Neurologic Symptoms Compared With Control Participants Without Infection or Neurologic Symptoms.
Edén A, Grahn A, Bremell D, Aghvanyan A, Bathala P, Fuchs D, Gostner J, Hagberg L, Kanberg N, Kanjananimmanont S, Lindh M, Misaghian S, Nilsson S, Schöll M, Sigal G, Stentoft E, Studahl M, Yilmaz A, Wang M, Stengelin M, Zetterberg H, Gisslén M. Edén A, et al. Among authors: scholl m. JAMA Netw Open. 2022 May 2;5(5):e2213253. doi: 10.1001/jamanetworkopen.2022.13253. JAMA Netw Open. 2022. PMID: 35604688 Free PMC article.
COVID-19 Recovery: Consistent Absence of Cerebrospinal Fluid Biomarker Abnormalities in Patients With Neurocognitive Post-COVID Complications.
Kanberg N, Grahn A, Stentoft E, Bremell D, Yilmaz A, Studahl M, Nilsson S, Schöll M, Gostner JM, Blennow K, Zetterberg H, Padmanabhan N, Cohen R, Misaghian S, Romero D, Campbell C, Mathew A, Wang M, Sigal G, Stengelin M, Edén A, Gisslén M. Kanberg N, et al. Among authors: scholl m. J Infect Dis. 2024 Feb 14;229(2):493-501. doi: 10.1093/infdis/jiad395. J Infect Dis. 2024. PMID: 37874918 Free PMC article.
Biomarkers for microglial activation in Alzheimer's disease.
Lautner R, Mattsson N, Schöll M, Augutis K, Blennow K, Olsson B, Zetterberg H. Lautner R, et al. Among authors: scholl m. Int J Alzheimers Dis. 2011;2011:939426. doi: 10.4061/2011/939426. Epub 2011 Nov 1. Int J Alzheimers Dis. 2011. PMID: 22114747 Free PMC article.
Prognostic value of Alzheimer's biomarkers in mild cognitive impairment: the effect of age at onset.
Altomare D, Ferrari C, Caroli A, Galluzzi S, Prestia A, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen CE, Wall A, Carter SF, Schöll M, Choo ILH, Grimmer T, Redolfi A, Nordberg A, Scheltens P, Drzezga A, Frisoni GB; Alzheimer’s Disease Neuroimaging Initiative. Altomare D, et al. Among authors: scholl m. J Neurol. 2019 Oct;266(10):2535-2545. doi: 10.1007/s00415-019-09441-7. Epub 2019 Jul 2. J Neurol. 2019. PMID: 31267207
18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease.
Mattsson N, Schöll M, Strandberg O, Smith R, Palmqvist S, Insel PS, Hägerström D, Ohlsson T, Zetterberg H, Jögi J, Blennow K, Hansson O. Mattsson N, et al. Among authors: scholl m. EMBO Mol Med. 2017 Sep;9(9):1212-1223. doi: 10.15252/emmm.201707809. EMBO Mol Med. 2017. PMID: 28743782 Free PMC article.
Biomarkers for tau pathology.
Schöll M, Maass A, Mattsson N, Ashton NJ, Blennow K, Zetterberg H, Jagust W. Schöll M, et al. Mol Cell Neurosci. 2019 Jun;97:18-33. doi: 10.1016/j.mcn.2018.12.001. Epub 2018 Dec 7. Mol Cell Neurosci. 2019. PMID: 30529601 Free PMC article. Review.
Plasma p-tau231, p-tau181, PET Biomarkers, and Cognitive Change in Older Adults.
Meyer PF, Ashton NJ, Karikari TK, Strikwerda-Brown C, Köbe T, Gonneaud J, Pichet Binette A, Ozlen H, Yakoub Y, Simrén J, Pannee J, Lantero-Rodriguez J, Labonté A, Baker SL, Schöll M, Vanmechelen E, Breitner JCS, Zetterberg H, Blennow K, Poirier J, Villeneuve S; Presymptomatic Evaluation of Experimental or Novel Treatments for Alzheimer Disease (PREVENT-AD) Research Group. Meyer PF, et al. Among authors: scholl m. Ann Neurol. 2022 Apr;91(4):548-560. doi: 10.1002/ana.26308. Epub 2022 Feb 18. Ann Neurol. 2022. PMID: 35084051
260 results